Table 1 Estimated costs used in the cost-effectiveness analysis of rTMS add-on treatment versus standard therapy
Cost item | Resource use | Unit cost | Cost | SD (± 20%) | Distribution |
|---|---|---|---|---|---|
rTMS treatment (acute treatment cost) | 660,4 EUR | 67,4 EUR | gamma | ||
assistant hour (25 × 1 hour) | 25 | 13,4 EUR | 336,0 EUR | ||
specialist hour (5 × 1 hour) | 5 | 24,7 EUR | 123,3 EUR | ||
office hours | 25 | 0,5 EUR | 13,3 EUR | ||
rTMS device use (sessions) | 25 | 6,2 EUR | 154,4 EUR | ||
native MR scan with (50% probability) | 50% | 59,9 EUR | 29,9 EUR | ||
standard EEG with (50% probability) | 50% | 7,0 EUR | 3,5 EUR | ||
rTMS maintenance cost per month | 56,6 EUR | 5,8 EUR | gamma | ||
assistant hour (2 × 1 hour per month) | 2 | 13,4 EUR | 26,9 EUR | ||
specialist hour (2X20 min per month) | 0,66 | 24,7 EUR | 16,3 EUR | ||
office hours (per month) | 2 | 0,5 EUR | 1,1 EUR | ||
rTMS device use (sessions per month) | 2 | 6,2 EUR | 12,4 EUR | ||
Hospitalization (DRG based) 40% probability | 40% | 945,5 EUR | 378,2 EUR | ||
Cost of ECT (DRG based) | 1,00 | 945,5 EUR | 945,5 EUR | ||
Drug therapy cost per month | 13,5 EUR | 1,4 EUR | gamma | ||
antidepressant switch | 47% | 8,0 EUR | 3,8 EUR | ||
antidepressant combination | 30% | 17,6 EUR | 5,3 EUR | ||
antidepressant & antipsychotic combination use | 23% | 19,5 EUR | 4,5 EUR |